Success Stories

Dreamed Diabetes

Developing innovative Artificial Pancreas Technology.

Dedicated to empowering insulin-dependent patients and their doctors with innovative and patient-centric decision support technology. The company was established in 2014 as a spin-off the DREAM International Consortium, in order to commercialize the artificial pancreas technology behind Glucositter.

Dreamed Diabetes
Share this Page:
Font Resize